169 related articles for article (PubMed ID: 2049787)
1. Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration.
Okumura M; Shirai T; Asamoto M; Ogiso T; Fukushima S
Cancer Lett; 1991 Jun; 58(1-2):81-5. PubMed ID: 2049787
[TBL] [Abstract][Full Text] [Related]
2. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S
Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
[TBL] [Abstract][Full Text] [Related]
3. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
[TBL] [Abstract][Full Text] [Related]
4. Uracil-induced calculi and carcinogenesis in the urinary bladder of rats treated simultaneously with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okumura M; Shirai T; Tamano S; Ito M; Yamada S; Fukushima S
Carcinogenesis; 1991 Jan; 12(1):35-41. PubMed ID: 1988179
[TBL] [Abstract][Full Text] [Related]
5. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
[TBL] [Abstract][Full Text] [Related]
6. Promoting effect of sodium chloride in 2-stage urinary bladder carcinogenesis in rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Shibata MA; Nakanishi K; Shibata M; Masui T; Miyata Y; Ito N
Urol Res; 1986; 14(4):201-6. PubMed ID: 3787885
[TBL] [Abstract][Full Text] [Related]
7. Absence of promoting potential of bracken fern (Pteridium aquilinum) in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine and uracil.
de Oliveira ML; Souza Rocha N; Fukushima S; de Camargo JL
Teratog Carcinog Mutagen; 1995; 15(4):191-9. PubMed ID: 8838633
[TBL] [Abstract][Full Text] [Related]
8. Differences in cell proliferation and apoptosis between reversible and irreversible mucosal lesions associated with uracil-induced urolithiasis in N-butyl-N-(4-hydroxybutyl)nitrosamine-pretreated.
Shirai T; Shibata M; Takahashi S; Tagawa Y; Imaida K; Hirose M
Carcinogenesis; 1995 Mar; 16(3):501-5. PubMed ID: 7697805
[TBL] [Abstract][Full Text] [Related]
9. Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hagiwara A; Tamano S; Ogiso T; Asakawa E; Fukushima S
Jpn J Cancer Res; 1990 Dec; 81(12):1232-8. PubMed ID: 2125992
[TBL] [Abstract][Full Text] [Related]
10. Promoting effect of monosodium aspartate, but not glycine, on renal pelvis and urinary bladder carcinogenesis in rat induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kitamura M; Konishi N; Kitahori Y; Fukushima Y; Yoshioka N; Hiasa Y
Toxicol Pathol; 1996; 24(5):573-9. PubMed ID: 8923678
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
12. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
Nakanowatari J; Fukushima S; Imaida K; Ito N; Nagase S
Jpn J Cancer Res; 1988 Apr; 79(4):453-9. PubMed ID: 3133335
[TBL] [Abstract][Full Text] [Related]
13. Effect of quercetin on two-stage carcinogenesis of the rat urinary bladder.
Hirose M; Fukushima S; Sakata T; Inui M; Ito N
Cancer Lett; 1983 Nov; 21(1):23-7. PubMed ID: 6640511
[TBL] [Abstract][Full Text] [Related]
14. Pathological analysis of the carcinogenicity of sodium o-phenylphenate and o-phenylphenol.
Fukushima S; Kurata Y; Ogiso T; Okuda M; Miyata Y; Ito N
Oncology; 1985; 42(5):304-11. PubMed ID: 4034146
[TBL] [Abstract][Full Text] [Related]
15. Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
Fukushima S; Kurata Y; Shibata M; Ikawa E; Ito N
Cancer Lett; 1984 May; 23(1):29-37. PubMed ID: 6744233
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemically demonstrated variation in expression of cathepsin E between uracil-induced papillomatosis and N-butyl-N-(4-hydroxybutyl)nitrosamine-induced preneoplastic and neoplastic changes in rat urinary bladder.
Yamamoto S; Yonezawa S; Ichinose M; Miki K; Masui T; Fukushima S; Inoue H; Tatematsu M
Virchows Arch; 1996 Mar; 427(6):589-94. PubMed ID: 8605570
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
[TBL] [Abstract][Full Text] [Related]
18. Renal pelvic carcinoma which shows metastatic potential to distant organs, induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
Murai T; Mori S; Hosono M; Takeuchi Y; Ohara T; Makino S; Takeda R; Hayashi Y; Fukushima S
Jpn J Cancer Res; 1991 Dec; 82(12):1371-7. PubMed ID: 1778760
[TBL] [Abstract][Full Text] [Related]
19. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM
Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of L-ascorbic acid, citric acid or their sodium salts on tumor induction by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-ethyl-N-(4-hydroxybutyl)nitrosamine in the rat urinary bladder.
Inoue T; Imaida K; Suzuki E; Okada M; Fukushima S
Cancer Lett; 1988 Jun; 40(3):265-73. PubMed ID: 3383181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
